Crown Holdings
CCKBusiness Overview
source: coverage-next-full ticker: CCK step: 01 title: Business Model & Value Chain date: 2026-06-11
Step 01 — Business Model: Crown Holdings, Inc. (CCK)
Business Description
Crown Holdings, Inc. (CCK) is a Pennsylvania-incorporated corporation founded in 1892, operating as one of the world's leading manufacturers of metal packaging primarily for beverage, food, and aerosol markets. [S1] The company manufactures aluminum beverage cans (its core product), steel crowns, glass bottles, aluminum caps, food cans, aerosol cans, and transit packaging products (steel/plastic strapping, protective packaging, automation equipment) through its Signode subsidiary. [S2]
Scale: 189 manufacturing plants in 39 countries, ~23,000 employees, ~$12.4B FY2025 revenue. Approximately 72% of net sales derive from global beverage cans; the remaining 28% spans Transit Packaging (Signode) and North American food/aerosol cans. [S1]
Value Chain Position
Raw Materials Manufacturing Customers End Consumer
───────────── ───────────── ───────── ────────────
Aluminum CCK converts raw AB InBev Beer drinker
(46% of COGS) ──────► aluminum coil into Coca-Cola ──────► Soda drinker
formed/filled PepsiCo Energy drink
Steel beverage cans Constellation consumer
(7% of COGS) ──────► for direct shipment Red Bull
to fillers
CCK sits in the metal can manufacturing layer of the beverage packaging supply chain. It is a "converter" — it purchases aluminum coil from primary aluminum producers (Alcoa, Novelis, etc.), stamps and lithographs cans, and delivers to beer, soda, and energy drink bottlers/fillers. [S1, S2]
Key Value Chain Characteristics:
- Pass-through pricing: Most long-term supply agreements include aluminum cost pass-through mechanisms, insulating margins from aluminum price swings but making reported revenue and headline margins somewhat artificial. [S2]
- Long-term contracts: CCK has multi-year supply agreements with major beverage brands. Switching costs are real: fillers co-invest in complementary canning lines and do not switch suppliers frequently. [S2]
- Capital density: The can manufacturing business is highly capital-intensive. A new greenfield aluminum can plant costs $150–400M depending on scale. CCK invested ~$2B+ in new capacity from 2019–2023. [S2]
Segment Architecture
| Segment | FY2024 Revenue | % of Total | FY2024 Seg. Income | Margin |
|---|---|---|---|---|
| Americas Beverage | $5,240M | 44.4% | $987M | 18.8% |
| Transit Packaging (Signode) | $2,107M | 17.9% | $270M | 12.8% |
| European Beverage | $2,071M | 17.6% | $276M | 13.3% |
| Other (food, aerosol, closures) | $1,222M | 10.4% | $82M | 6.7% |
| Asia Pacific | $1,161M | 9.8% | $195M | 16.8% |
| Total | $11,801M | 100% | $1,810M | 15.3% |
[S2]
Americas Beverage (44% of revenue)
The dominant segment. Manufactures aluminum beverage cans and ends in the U.S., Brazil, Canada, Colombia, and Mexico. Key growth driver: Brazil volumes up 10% in FY2024; NA volumes up 7%. Segment income margin expanded from 14.5% (2022) to 18.8% (2024) as new capacity (Martinsville VA, Mesquite NV, Uberaba Brazil, Monterrey Mexico) ramped. This segment is CCK's moat anchor — top-two market position in North America with Ball Corporation. [S2]
Transit Packaging / Signode (18% of revenue)
Acquired from Carlyle Group in 2018 for ~$3.9B. Produces steel and plastic strapping, protective packaging (airbags, honeycomb), and automation/end-of-line equipment for industrial manufacturers. End markets: metals, construction, agriculture, food/beverage manufacturing. This segment has been a consistent underperformer since acquisition — revenue declined from $2,545M (2022) to $2,107M (2024) as industrial production weakened and commodity cost pass-throughs reversed. Management views it as a cash generation asset, not a growth platform. [S2]
European Beverage (18% of revenue)
Manufactures aluminum beverage cans across Pan-European and MENA markets. Margin recovery has been dramatic: from 5.8% (2022) to 13.3% (2024) as European volumes inflected (+7% in FY2024) and start-up costs from new greenfields (Peterborough UK, Agoncillo Spain) normalized. This segment represents CCK's best organic growth runway over the next 3–5 years as European can penetration of the total beverage market is lower than North America. [S2]
Asia Pacific (10% of revenue)
Manufactures beverage cans, food cans, and specialty packaging across Southeast Asia (Cambodia, Vietnam, Thailand, Indonesia, Malaysia, China, Myanmar). FY2024 volumes were -7% due to Thailand-Cambodia border conflict disruptions and regional consumer weakness. Management expects these headwinds to fully lap by Q3 2026. Myanmar plant idled since June 2022. Sihanoukville Cambodia plant announced for closure Q4 2024. [S2]
Other — Food, Aerosol, Closures (10% of revenue)
North American food cans, aerosol cans, and closures. This is a declining and non-core segment — revenue fell from $1,543M (2022) to $1,222M (2024). Management has been rationalizing: Decatur IL aerosol plant closed Q4 2023, La Villa Mexico food can plant closed Q2 2024. This segment's decline will continue as CCK focuses on beverage cans. [S2]
Revenue Model
Crown Holdings generates revenue in three primary ways:
Can + end sales: Per-unit pricing to beverage fillers (Coca-Cola, AB InBev, PepsiCo, Constellation, etc.) under long-term supply agreements. Pricing includes a commodity pass-through component (aluminum, steel) + a conversion margin. Volume is the key driver; price/mix is secondary.
Transit packaging consumables: Steel and plastic strapping, protective packaging, and industrial film sold on a recurring consumable basis to industrial manufacturers. Pricing is semi-contractual with commodity pass-through.
Equipment and automation (Signode): Capital equipment sales (strapping machines, end-of-line automation) — lower-margin but creates installed base for consumables (razors-and-blades model).
Revenue quality: High recurring visibility (long-term can contracts), moderate pricing power (oligopolistic markets with 2–3 key players in most regions), low spot/discretionary exposure. [S2]
Customer Concentration
Crown Holdings does not publicly disclose individual customer revenue percentages, but management commentary indicates no single customer exceeds 10% of consolidated net sales. Key relationships include AB InBev, Coca-Cola, PepsiCo, Constellation Brands, and Red Bull (Americas/Europe) plus Heineken (new India anchor customer for 2027 greenfield). [S10]
Competitive Positioning
CCK is the #2 global aluminum beverage can manufacturer behind Ball Corporation (BALL). In North America, CCK and Ball together control ~55–65% of aluminum beverage can capacity, creating rational duopoly pricing dynamics. In Europe, the landscape is more competitive with Ardagh Metal Packaging and the disruptive Canpack (private, Poland-based aggressive greenfield builder). [S7]
Source Index
| Code | Source |
|---|---|
| S1 | SEC EDGAR XBRL — xbrl/xbrl_summary.md |
| S2 | Crown Holdings 10-K FY2024 — sec_filings/10K_FY2024_summary.md |
| S7 | Competitive landscape research — industry/competitive_landscape.md |
| S10 | Investor presentation — presentations/investor_presentation_2024.md |
Financial Snapshot
source: coverage-next-full ticker: CCK step: 04 title: Financial Quality & Adversarial Research Sweep date: 2026-06-11
Step 04 — Financial Quality: Crown Holdings (CCK)
Statement Quality Overview
Crown Holdings' financial statements are prepared under US GAAP with consistent accounting policies. The company is a mature, large-cap industrial with established auditors (PricewaterhouseCoopers LLP) and Big 4 audit coverage. No material restatements, SEC inquiries, or going-concern issues were identified in the filing review. [S3]
Key Quality Observation: CCK's GAAP results include significant non-operating items that obscure true operating performance:
- Pension settlement charges — Q3 2024 recorded large charges for partial U.S. pension plan settlement, driving reported net income to -$175M in Q3 2024.
- Goodwill impairments — FY2021 reported $560M net loss primarily from goodwill impairment charges.
- One-time tax items — FY2024 included $64M U.S. tax charge related to Eviosys distribution.
- Intangibles amortization — Related primarily to Signode acquisition; excluded from segment income.
Adjusted EPS (management's preferred metric) strips these items: FY2025 Adj. EPS of $7.79 vs. GAAP EPS of $6.38. [S4]
Income Statement Quality
Revenue Recognition
Crown Holdings recognizes revenue when control of products is transferred to the customer (ASC 606). The pass-through nature of aluminum pricing means reported revenue fluctuates with commodity prices even if underlying volumes and conversion margins are stable. This is structural accounting behavior, not manipulation. [S2]
Segment Income Definition
Segment income is a non-GAAP metric: GAAP operating income adjusted to exclude:
- Intangible amortization (primarily Signode purchase price allocation)
- Restructuring charges
- Fair value adjustments on acquired inventory
This is consistent with how packaging peers report segment profitability and provides a better view of ongoing conversion margin. [S2]
SBC (Stock-Based Compensation)
SBC has risen from $29M (FY2022) to $48M (FY2025). As a percentage of revenue, SBC is ~0.4% — immaterial and within normal range for a capital-intensive industrial. Not a quality concern. [S1]
Effective Tax Rate
- FY2024: 24.6%
- FY2023: 27.9%
- FY2022: 23.0%
Tax rate is volatile year-to-year due to geographic profit mix and non-recurring items (FY2024 Eviosys tax charge, FY2024 pension-related tax benefit). Normalized rate is approximately 25–27%. [S2]
Balance Sheet Quality
Working Capital
- Current ratio: 1.22x (FY2024), 1.03x (FY2025)
- Quick ratio: 0.74x (FY2024), 0.59x (FY2025)
Working capital is tight but adequate for a capital-intensive industrial that runs with minimal excess cash. Q1 is seasonally negative for OCF due to working capital build (inventory). [S4]
Goodwill and Intangibles
The Signode acquisition ($3.9B in 2018) created significant goodwill and intangibles. FY2021 included a goodwill impairment charge — a signal that the acquisition was overpriced or that Signode's value was lower than expected. Current goodwill balance is not broken out precisely in available data, but implied from the total assets structure. This is a watch item if Signode performance continues to disappoint. [S2]
Pension Obligations
CCK has significant defined benefit pension obligations. In Q3 2024, the company executed a partial U.S. pension plan settlement (transferring obligations to an insurance carrier), recording a large non-cash charge. The remaining pension obligations are estimated but have been partially derisked through this settlement. Future pension contributions will be lower. [S2]
Receivables Securitization
CCK operates receivables securitization facilities (U.S. $800M program, expired July 2025; additional facilities totaling ~$390M, expired Nov 2025). These were off-balance-sheet financing tools that reduce reported working capital needs. Expiry of these facilities in mid-2025 may have modestly increased reported gross receivables. [S2]
Cash Flow Statement Quality
OCF-to-Net Income Conversion
| Year | Net Income | OCF | Conversion Ratio |
|---|---|---|---|
| 2025 | $738M | $1,530M | 2.07x |
| 2024 | $424M | $1,192M | 2.81x |
| 2023 | $450M | $1,453M | 3.23x |
| 2022 | $727M | $803M | 1.10x |
High OCF/NI ratios in 2023–2025 reflect (1) high D&A relative to CapEx, (2) non-cash items (pension charges, goodwill), and (3) working capital cycling. The ~2x+ conversion is expected for a capital-intensive industrial with these D&A levels. No quality concern. [S1]
CapEx Normalization
The step-down from $839M (2022) to $403M (2024) to $413M (2025) is the core FCF inflection story. This is genuine — major greenfield projects in Virginia, Nevada, Brazil, and UK are mechanically complete. The FY2026 guidance of ~$550M is slightly elevated (India greenfield investment beginning) but still materially below peak. [S2]
Adversarial Research Sweep
Note: This analysis is based on filings, press releases, and public court records. No earnings call transcripts were reviewed (coverage-next-full path). No short-seller or activist reports were identified targeting CCK specifically.
Claim 1: Asbestos Liability — Is It Bounded?
Bear claim: Crown Cork & Seal (a predecessor entity) acquired a portion of Mundet Cork Corporation in 1963, which manufactured asbestos-containing products. Plaintiffs have alleged Crown Holdings (as successor) is liable for decades of asbestos exposure claims.
Assessment: The key protection is Pennsylvania statute 42 Pa.C.S. §5303, which specifically caps Crown Cork's liability to claims where the plaintiff had actual occupational contact with Crown Cork's asbestos products. This statute has survived repeated legal challenges. CCK consistently settles hundreds of claims annually at a bounded level. Annual asbestos settlement costs are typically $60–100M/year based on historical filings. The risk is not zero — federal legislation could preempt the PA statute — but current trajectory suggests this is a manageable, recurring cost, not an existential liability. [S2] Fact vs. Judgment: Judgment (PA statute durability)
Claim 2: Signode Acquisition — Was It a Value Destroyer?
Bear claim: CCK paid ~$3.9B for Signode in 2018 at a peak industrial valuation. Signode revenue has declined from $2,545M (2022) to $2,107M (2024). Goodwill impairment in FY2021 validates the bear case.
Assessment: The FY2021 impairment charge confirms that Signode was overvalued at acquisition, at least temporarily. However, Signode still generates $270M+ of segment income annually at a ~12.8% margin, creating meaningful FCF. The question is whether Signode is worth its ~$2.5–3.0B implied enterprise value today. If CCK were to sell/spin Signode, the remaining pure-play beverage can business would likely re-rate significantly higher (closer to Ball's multiple). This is a legitimate bear/catalyst thesis. [S2, S4] Fact vs. Judgment: Mixed
Claim 3: BPA Regulatory Risk
Bear claim: CCK's can coatings historically used bisphenol-A (BPA), a chemical facing regulatory scrutiny globally (EU classification as SVoC, potential U.S. FDA action).
Assessment: CCK (and the broader industry) has been transitioning to BPA-free coatings since 2018. The 2024 10-K still mentions BPA as a risk factor but notes the transition is ongoing. This is a legitimate tail risk but not a near-term earnings threat. The industry has a multi-year track record of managing BPA regulatory transitions without major disruption. [S2] Fact: Disclosed risk factor
Claim 4: European Overcapacity Risk
Bear claim: Canpack's aggressive greenfield buildout in Europe (and now the U.S.) could reprice the European beverage can market, compressing CCK's recovering European margins.
Assessment: This is the most credible medium-term risk. Canpack has opened multiple EU plants since 2021 and is reportedly building its first U.S. facility. Excess capacity in regional markets creates pricing pressure. CCK's European margin recovery from 5.8% to 13.3% could stall or reverse if Canpack disrupts pricing. The bull counter-argument: Canpack is building to serve long-term contracts, not to reprice the market; European can demand growth (5%+ p.a.) should absorb new capacity. Fact vs. Judgment: Judgment — key thesis risk
No Material Red Flags Found
- No SEC enforcement actions or formal investigations
- No recent shareholder derivative lawsuits of significance
- No activist campaigns targeting CCK (as of June 2026)
- No forensic accounting flags (channel stuffing, revenue pull-forward) in the available data
Financial Quality Summary
| Dimension | Assessment | Note |
|---|---|---|
| Revenue recognition | Clean | Pass-through mechanics clearly disclosed |
| GAAP vs. adjusted gaps | Moderate | Pension + goodwill + intangibles amortization distort GAAP; adjusted metrics are more representative |
| Cash conversion | High | OCF consistently exceeds net income |
| CapEx guidance accuracy | High | FY2024 actual $403M vs. guidance ~$400–450M |
| Debt transparency | Adequate | Detailed debt schedule in 10-K; off-balance-sheet structures (A/R securitization) disclosed |
| Auditor | PwC — Clean opinions | No material weaknesses noted |
| Asbestos liability | Bounded but real | PA statute protective; annual cost manageable |
| Goodwill/Impairment risk | Moderate | Signode impairment risk if revenue/margin decline resumes |
Source Index
| Code | Source |
|---|---|
| S1 | SEC EDGAR XBRL — xbrl/xbrl_summary.md |
| S2 | Crown Holdings 10-K FY2024 — sec_filings/10K_FY2024_summary.md |
| S3 | Filing inventory — sec_filings/filing_inventory.md |
| S4 | StockAnalysis.com — other/stockanalysis_summary.md |
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $CCK.